Fifth Lane Capital’s Merck MRK Stock Holding History

Fifth Lane Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,000	Closed	-$3.71M	–	83
2024 Q2	$3.71M	Buy	+30,000	New	+$3.86M	5.38%	4

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fifth Lane Capital's MRK Position: Q3 2024 in Review

Fifth Lane Capital sold out of Merck (MRK) in Q3 2024, closing a stake of 30,000 shares — an estimated $3.71M sold.

Fifth Lane Capital first reported a position in MRK in Q2 2024 and held it in 1 quarter. The position peaked at $3.71M in Q2 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Fifth Lane Capital reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Fifth Lane Capital sold 30,000 Merck shares in Q3 2024, an estimated $3.71M.
Fifth Lane Capital first reported a position in Merck in Q2 2024 and held it in 1 quarter.
Fifth Lane Capital's Merck position peaked at $3.71M in Q2 2024.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Fifth Lane Capital's 13F filing for Q3 2024, filed 12 Nov 2024.